GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List

Range Low Price High Price Comment
30 days $2.30 $2.95 Thursday, 18th Apr 2024 CLLS stock ended at $2.47. This is 0.407% more than the trading day before Wednesday, 17th Apr 2024. During the day the stock fluctuated 14.35% from a day low at $2.30 to a day high of $2.63.
90 days $2.30 $3.13
52 weeks $0.96 $3.77

Historical Cellectis S.A. prices

Date Open High Low Close Volume
2021-08-11 $13.97 $13.97 $12.58 $12.95 596 835
2021-08-10 $14.34 $14.50 $13.77 $14.04 148 504
2021-08-09 $14.62 $15.10 $14.40 $14.79 238 524
2021-08-06 $14.35 $14.45 $13.80 $14.28 194 481
2021-08-05 $13.36 $13.99 $13.35 $13.71 158 658
2021-08-04 $13.72 $14.02 $13.07 $13.33 230 977
2021-08-03 $13.82 $13.97 $13.28 $13.62 98 925
2021-08-02 $13.54 $13.92 $13.33 $13.64 131 593
2021-07-30 $13.36 $13.65 $12.55 $12.95 184 044
2021-07-29 $13.81 $13.95 $13.26 $13.28 102 985
2021-07-28 $13.33 $13.88 $13.25 $13.70 119 647
2021-07-27 $13.09 $13.14 $12.62 $12.99 147 387
2021-07-26 $13.86 $13.87 $12.81 $13.17 276 249
2021-07-23 $14.30 $14.30 $13.61 $13.75 116 022
2021-07-22 $14.41 $14.49 $13.82 $13.85 76 582
2021-07-21 $14.21 $14.41 $13.94 $14.38 146 203
2021-07-20 $13.59 $14.00 $13.34 $14.00 202 447
2021-07-19 $13.75 $13.96 $13.52 $13.73 134 349
2021-07-16 $13.82 $14.37 $13.47 $14.15 140 564
2021-07-15 $13.70 $13.85 $13.13 $13.68 255 829
2021-07-14 $14.97 $14.97 $13.83 $13.94 282 968
2021-07-13 $15.39 $15.42 $14.70 $14.74 167 967
2021-07-12 $15.65 $15.84 $15.12 $15.58 202 294
2021-07-09 $15.14 $15.79 $14.90 $15.78 341 567
2021-07-08 $13.95 $14.51 $13.55 $14.44 175 693
Click to get the best stock tips daily for free!

About Cellectis S.A.

Cellectis S.A. Cellectis S.A., a clinical stage biotechnological company, develops immuno-oncology products based on gene-edited T-cells that express chimeric antigen receptors to target and eradicate cancer cells. It operates through two segments, Therapeutics and Plants. The company is developing UCART19, an allogeneic T-cell product candidate for the treatment of CD19-expressing hematologic malignancies, such as acute lymphoblastic leukemia; ALLO-501 and ALL... CLLS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT